Tag: Salford Lung Study

GSK’s inhaler improves asthma control in ‘real world’ study

by Selina McKee | May 8, 2017 | News | 0

GlaxoSmithKline and Innoviva have unveiled data from a second ground-breaking Salford Lung Study (SLS) showing that Relvar Ellipta significantly improved asthma control versus patients’ standard therapy.

GSK’s Relvar Ellipta shows benefit for COPD patients

by Selina McKee | Sep 5, 2016 | News | 0

Further results from the UK Salford Lung Study have been unveiled showing that GlaxoSmithKline’s Relvar Ellipta is better than the standard of care in reducing exacerbations in patients with chronic obstructive pulmonary disease.